TerminatedNCT02156115
Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Studying Congenital pulmonary lymphangiectasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Joel Moss, M.D.National Heart, Lung, and Blood Institute (NHLBI)
- Enrollment
- 14 enrolled
- Eligibility
- 2-90 years · All sexes
- Timeline
- 2015 – 2024
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02156115 on ClinicalTrials.gov